Advertisement
Screener

Unity Biotechnology, Inc. Operating Income

Unity Biotechnology, Inc. Operating Income

Unity Biotechnology, Inc. reported Operating Income of -$6.89 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2025-04-22

  • Unity Biotechnology, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$6.89M.
  • Unity Biotechnology, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$9.99M.
  • Unity Biotechnology, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$6.60M.
  • Unity Biotechnology, Inc. operating income (loss) for the quarter ending 2024-06-30 was -$6.98M.
  • Unity Biotechnology, Inc. operating income (loss) for fiscal 2024 was -$31.17M.
  • Unity Biotechnology, Inc. operating income (loss) for fiscal 2023 was -$44.67M.
  • Unity Biotechnology, Inc. operating income (loss) for fiscal 2022 was -$57.57M.
  • Unity Biotechnology, Inc. operating income (loss) for fiscal 2021 was -$56.66M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 month
2025-03-31-$6.89M
10-Q · filed 2025-04-22
-$16.88M
derived: sum of 2 quarters · filed 2025-04-22
-$23.48M
derived: sum of 3 quarters · filed 2025-04-22
-$30.46M
derived: sum of 4 quarters · filed 2025-04-22
2024-12-31-$9.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$16.59M
derived: sum of 2 quarters · filed 2025-03-07
-$23.57M
derived: sum of 3 quarters · filed 2025-03-07
-$31.17M
10-K · filed 2025-03-07
2024-09-30-$6.60M
10-Q · filed 2024-11-04
-$13.58M
derived: sum of 2 quarters · filed 2024-11-04
-$21.18M
10-Q · filed 2024-11-04
-$28.86M
derived: sum of 4 quarters · filed 2025-04-22
2024-06-30-$6.98M
10-Q · filed 2024-08-06
-$14.58M
10-Q · filed 2024-08-06
-$22.25M
derived: sum of 3 quarters · filed 2025-04-22
-$36.84M
derived: sum of 4 quarters · filed 2025-04-22
2024-03-31-$7.60M
10-Q · filed 2025-04-22
-$15.28M
derived: sum of 2 quarters · filed 2025-04-22
-$29.86M
derived: sum of 3 quarters · filed 2025-04-22
-$41.70M
derived: sum of 4 quarters · filed 2025-04-22
2023-12-31-$7.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$22.26M
derived: sum of 2 quarters · filed 2025-03-07
-$34.11M
derived: sum of 3 quarters · filed 2025-03-07
-$44.67M
10-K · filed 2025-03-07
2023-09-30-$14.58M
10-Q · filed 2024-11-04
-$14.93M
10-Q · filed 2023-11-13
-$26.43M
derived: sum of 2 quarters · filed 2024-11-04
-$36.99M
10-Q · filed 2024-11-04
-$37.55M
10-Q · filed 2023-11-13
-$50.03M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30-$11.85M
10-Q · filed 2024-08-06
-$11.96M
10-Q · filed 2023-08-08
-$22.41M
10-Q · filed 2024-08-06
-$22.62M
10-Q · filed 2023-08-08
-$35.45M
derived: sum of 3 quarters · filed 2025-03-07
-$49.45M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31-$10.56M
10-Q · filed 2024-05-14
-$10.65M
10-Q · filed 2023-05-09
-$23.60M
derived: sum of 2 quarters · filed 2025-03-07
-$37.60M
derived: sum of 3 quarters · filed 2025-03-07
-$49.86M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31-$13.04M
derived: 10-K 12 month − 10-K 9 month · filed 2025-03-07
-$27.05M
derived: sum of 2 quarters · filed 2025-03-07
-$39.30M
derived: sum of 3 quarters · filed 2025-03-07
-$57.57M
10-K · filed 2025-03-07
2022-09-30-$14.01M
10-K · filed 2024-04-15
-$13.13M
10-Q · filed 2022-11-08
-$26.27M
derived: sum of 2 quarters · filed 2024-04-15
-$44.53M
10-K · filed 2024-04-15
-$43.66M
10-Q · filed 2022-11-08
-$54.43M
derived: sum of 4 quarters · filed 2024-04-15
2022-06-30-$12.26M
10-Q · filed 2023-08-08
-$30.52M
10-Q · filed 2023-08-08
-$40.42M
derived: sum of 3 quarters · filed 2024-04-15
-$55.25M
derived: sum of 4 quarters · filed 2024-04-15
2022-03-31-$18.27M
10-Q · filed 2023-05-09
-$28.16M
derived: sum of 2 quarters · filed 2024-04-15
-$42.99M
derived: sum of 3 quarters · filed 2024-04-15
-$59.99M
derived: sum of 4 quarters · filed 2024-04-15
2021-12-31-$9.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
-$24.73M
derived: sum of 2 quarters · filed 2024-04-15
-$41.72M
derived: sum of 3 quarters · filed 2024-04-15
-$56.66M
10-K · filed 2024-04-15
2021-09-30-$14.83M
10-Q · filed 2022-11-08
-$31.82M
derived: sum of 2 quarters · filed 2022-11-08
-$46.77M
10-Q · filed 2022-11-08
-$65.55M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$17.00M
10-Q · filed 2022-08-12
-$31.94M
10-Q · filed 2022-08-12
-$50.72M
derived: sum of 3 quarters · filed 2022-08-12
-$75.36M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$14.94M
10-Q · filed 2022-05-10
-$33.73M
derived: sum of 2 quarters · filed 2022-05-10
-$58.37M
derived: sum of 3 quarters · filed 2022-05-10
-$81.72M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$18.78M
10-K · filed 2021-03-23
-$43.42M
derived: sum of 2 quarters · filed 2021-11-10
-$66.77M
derived: sum of 3 quarters · filed 2021-11-10
-$93.93M
10-K · filed 2023-03-15
2020-09-30-$24.64M
10-Q · filed 2021-11-10
-$47.99M
derived: sum of 2 quarters · filed 2021-11-10
-$75.15M
10-Q · filed 2021-11-10
-$98.24M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$23.35M
10-Q · filed 2021-08-10
-$50.51M
10-Q · filed 2021-08-10
-$73.59M
derived: sum of 3 quarters · filed 2021-08-10
-$95.95M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31-$27.16M
10-Q · filed 2021-05-11
-$50.25M
derived: sum of 2 quarters · filed 2021-05-11
-$72.60M
derived: sum of 3 quarters · filed 2021-05-11
-$97.07M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31-$23.09M
10-K · filed 2021-03-23
-$45.44M
derived: sum of 2 quarters · filed 2021-03-23
-$69.91M
derived: sum of 3 quarters · filed 2021-03-23
-$89.65M
10-K · filed 2022-03-15
2019-09-30-$22.35M
10-K · filed 2021-03-23
-$46.82M
derived: sum of 2 quarters · filed 2021-03-23
-$66.56M
10-Q · filed 2020-11-04
-$89.37M
derived: sum of 4 quarters · filed 2021-03-23
2019-06-30-$24.47M
10-K · filed 2021-03-23
-$44.21M
10-Q · filed 2020-07-31
-$67.02M
derived: sum of 3 quarters · filed 2021-03-23
-$86.39M
derived: sum of 4 quarters · filed 2021-03-23
2019-03-31-$19.74M
10-K · filed 2021-03-23
-$42.55M
derived: sum of 2 quarters · filed 2021-03-23
-$61.92M
derived: sum of 3 quarters · filed 2021-03-23
-$82.72M
derived: sum of 4 quarters · filed 2021-03-23
2018-12-31-$22.81M
10-K · filed 2020-03-11
-$42.19M
derived: sum of 2 quarters · filed 2020-03-11
-$62.98M
derived: sum of 3 quarters · filed 2020-03-11
-$79.47M
10-K · filed 2021-03-23
2018-09-30-$19.38M
10-K · filed 2020-03-11
-$40.17M
derived: sum of 2 quarters · filed 2020-03-11
-$56.66M
10-Q · filed 2019-11-06
-$69.44M
derived: sum of 4 quarters · filed 2020-03-11
2018-06-30-$20.80M
10-K · filed 2020-03-11
-$37.28M
10-Q · filed 2019-08-07
-$50.07M
derived: sum of 3 quarters · filed 2020-03-11
-$62.15M
derived: sum of 4 quarters · filed 2020-03-11
2018-03-31-$16.48M
10-K · filed 2020-03-11
-$29.27M
derived: sum of 2 quarters · filed 2020-03-11
-$41.35M
derived: sum of 3 quarters · filed 2020-03-11
-$53.05M
derived: sum of 4 quarters · filed 2020-03-11
2017-12-31-$12.79M
10-K · filed 2019-03-06
-$24.87M
derived: sum of 2 quarters · filed 2019-03-06
-$36.57M
derived: sum of 3 quarters · filed 2019-03-06
-$45.61M
10-K · filed 2020-03-11
2017-09-30-$12.08M
10-K · filed 2019-03-06
-$23.78M
derived: sum of 2 quarters · filed 2019-03-06
-$32.82M
10-Q · filed 2018-11-07
2017-06-30-$11.70M
10-K · filed 2019-03-06
-$20.74M
10-Q · filed 2018-08-09
2017-03-31-$9.04M
10-K · filed 2019-03-06
2016-12-31-$18.84M
10-K · filed 2019-03-06